These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prognostic value of pleural fluid pH in malignant epithelial mesothelioma after talc poudrage. Aelony Y, Yao JF, King RR. Respiration; 2006; 73(3):334-9. PubMed ID: 16679752 [Abstract] [Full Text] [Related]
5. Can serum inflammatory parameters estimate outcome of pleurodesis in mesothelioma? Bilgin M, Hasdiraz L, Ozkaya M, Oguzkaya F. ANZ J Surg; 2007 Apr; 77(4):253-5. PubMed ID: 17388830 [Abstract] [Full Text] [Related]
14. [Thoracoscopy in malignant pleural effusions]. Zhang D, Chen Y, Tu C. Zhonghua Zhong Liu Za Zhi; 1996 Mar; 18(2):123-6. PubMed ID: 9206045 [Abstract] [Full Text] [Related]
15. Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma? Zahid I, Sharif S, Routledge T, Scarci M. Interact Cardiovasc Thorac Surg; 2011 May; 12(5):812-7. PubMed ID: 21345818 [Abstract] [Full Text] [Related]
16. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma. Neragi-Miandoab S, Richards WG, Sugarbaker DJ. Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112 [Abstract] [Full Text] [Related]
18. [Thoracoscopy in pleural mesothelioma]. Zhang DH, Gu YT, Pan WS. Zhonghua Jie He He Hu Xi Za Zhi; 1993 Jun; 16(3):150-3, 187. PubMed ID: 8242812 [Abstract] [Full Text] [Related]